FOREIGN TRADE BANK OF LATIN AMERICA, INC. (BLX): what the price assumes

In the published model solve dated 2026-Q2, anchored at $57.89, FOREIGN TRADE BANK OF LATIN AMERICA, INC. (BLX) is priced for 12.5% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/BLX

Headline

FieldValue
TickerBLX
CompanyFOREIGN TRADE BANK OF LATIN AMERICA, INC.
Sector / IndustryFinancial Services
Current price$57.89/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Price-to-book1.59x
Return on equity now15.4%

The implied return on book is non-physical at this price-to-book and is suppressed as misleading. The price sits beyond a 11.7% return on equity sustained for 40 years and is not resolvable as a sustainable-ROE point. The rarity read below is the honest signal.

Solve inputs: computed at a 9.4% cost of equity; ROE searched up to the 11.7% ROE ceiling.

How unusual the bet is: extreme

ReferenceValue
vs own history+1.24σ
cohort percentile (of 163 peers)76
sustained it ~10 years at this level68%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.85x3justifies
Earnings0.64x2justifies
Relative0.30x3justifies
Growth0.75x2justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.3%); the inversion above states its own rate.

Per-Model Detail (n=10)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$89.030.65xyesTBVPS $36.40 × 2.45x (ROE (TTM) 15.4% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$67.200.86xyesP/E 10x (static sector reference · 2026-04), scenarios: 8.0x / 10.0x / 12.0x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowthno
Two-Stage DDMGrowth$70.950.82xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$60.580.96xyesBV/sh $36.40, ROE (TTM) 15.4%, ke 9.3%
Two-Stage Excess ReturnAsset$77.200.75xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$84.000.69xyesRev $0.3B, growth 30% (input: historical growth; tapered), Terminal P/S: 5.6x / 7.0x / 8.4x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$196.000.30xyesEPS $5.60, growth 35% (input: historical EPS growth), PEG=0.30 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$67.720.85xyes√(22.5 × EPS $5.60 × BVPS $36.40) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$180.690.32xyesEPS $5.60 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelative$210.000.28xyesEPS $5.60 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$60.540.96xyesEPS $5.60 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Roughly 1.6 times book value is what this bank costs today, the top of its comparison group, and the number only makes sense next to what the bank has been earning on that book: a return on equity of about 15.4%. That figure needs a benchmark to mean anything. Money committed to a lender of this risk profile is conventionally reckoned to cost around 9.4% a year, so the business has been clearing its own hurdle by roughly six percentage points. Clear a hurdle like that and the shares are, arithmetically, worth more than the book they sit on. The question is never whether the premium is deserved today. It is how long the spread lasts.

What makes this particular spread unusual is the structure underneath it. Bladex lends into Latin American trade, and it lends short. The 20-F puts the portfolio's average remaining maturity term of 504 days, and 65% of the Bank's Loan Portfolio was scheduled to mature within one year. Translate that and the risk management becomes obvious: a bank whose book runs off inside two years does not need to sell anything to shrink. It simply declines to renew. When a country's outlook deteriorates, the exposure walks out of the door on its own schedule rather than having to be marked down and sold to someone.

The funding side is stranger and stronger. This is a bank whose shareholders include the central banks of the countries it lends into. The 20-F acknowledges the arrangement while flagging its risk, referring to levels of deposits made by central banks and their designees (i.e., the Bank's Class A shareholders). No regional lender anywhere can assemble that depositor list. It is the reason a comparatively small institution can fund dollar trade finance across a region where dollar liquidity is otherwise expensive and intermittent.

Liquidity has been building rather than thinning. The bank carried about 1.9 billion dollars of liquid assets at the end of 2025, and the liquidity index reported by the Bank to the regulator as of December 31, 2025 was 60.7 % (2024: 47.2 %). That is a large move in one year, and it is the kind of change a management team makes when it wants optionality rather than yield.

Capital return says the board agrees with the operating picture. The quarterly dividend was raised to $0.6875 a share from $0.625. Raising the payout while the return on capital sits well above its cost is management telling owners it does not need the retained dollar as badly as they might. For a bank, that is the most direct statement of confidence available.

Bear Case

Trade-finance banking earns its best returns when rates are elevated, dollar liquidity in the region is scarce enough to price well, and Latin American credit behaves. All three conditions have been in place. None of them is permanent, and the price treats the combination as if it were.

That is the peak-versus-sustainable question, and here it has an unusually precise shape. The bank has recently been earning about 15.4% on equity. That is a strong figure for any lender and a notable one for a wholesale-funded institution. The trouble is what the share price does with it. At around 1.6 times book, the price does not merely need that level to hold; it needs it to hold beyond the band where long-lived franchises historically come to rest, and the requirement is not resolvable as a durable point at all. Where does that band top out? Among institutions that kept an edge alive across four decades, somewhere near 11.7%. Even taken at face value, only about 67% of firms delivering at this level held it for a decade. The bank's own record puts the assumed return within reach, so this is not a bet on new capability. It is a bet on duration, and duration is the thing cycles remove.

Credit is where a cycle would show first, and the direction has already changed. The 20-F's roll-forward of credit-impaired loans shows exposures newly classified as credit-impaired during the year rising to about 10.3 million dollars in 2025 from roughly 1.5 million dollars in 2024. On a balance sheet with total liabilities above ten billion dollars these are small absolute figures, and it would be wrong to call them a problem. The point is that the denominator of the return on equity is capital, and provisions come straight out of it. The filing is explicit that each exposure is rated using the customer risk and country risk ratings, which means a sovereign downgrade reprices a book of otherwise performing corporate loans.

The country channel runs further than provisions. The 20-F warns that increased risk perception in any country where the Bank has large exposures could trigger downgrades to the Bank's credit ratings, and its ratings determine what it pays for funding. So a political event in one country can widen the bank's own cost of money without a single borrower missing a payment. That is a transmission mechanism a domestically funded lender simply does not have.

The spread economics are thinner than a retail bank's, which is why volume and credit costs carry so much of the result. ONB, a domestically funded regional lender, reported a net interest margin of 3.54%, a level a wholesale-funded trade bank does not reach. Bladex compensates with low credit losses and fee income, and low credit losses are precisely the line that mean-reverts hardest when a region turns. Meanwhile the price-to-book sits at the very top of its peer group, which means the market has already awarded the benefit of the doubt on every one of these questions.

Valuation

A bank is worth the return it earns on the capital entrusted to it, which is why the price here reads off book value rather than any operating multiple. At about 1.6 times book, the market is paying for a level of profitability that sits beyond where long-lived franchises historically settle, and the requirement does not resolve into a durable figure at all. It is a bound, not a solved answer.

Put the relevant levels side by side. Franchises that held their edge across four decades settled somewhere near 11.7%. This bank has lately been earning about 15.4% on its equity. The gap between those two figures is what the whole argument turns on, and closing it requires nothing to go wrong, only for conditions to normalise.

Three checks sit around that bound and they do not all point the same way. Against its own record, the assumed return is within reach of what this bank has already delivered, so nothing new is being demanded of the franchise. Against history, only about 67% of firms earning a return at this level sustained it for a decade. Against peers, the price-to-book sits at the very top of the group. The demand is therefore about persistence rather than capability.

Here the report's own methods disagree with that reading, and the disagreement is the analytical question rather than something to resolve. Every family of method lands above today's price. The bank-specific read is the one worth taking seriously: it multiplies tangible book of $36.40 a share by a multiple derived directly from the trailing return on equity set against the cost of equity, and it lands comfortably above the current quote. The generic earnings and peer-multiple screens land further above still, but those extrapolate historical per-share growth mechanically and are built for industrial companies rather than for a lender. The frames diverge on one thing: whether the profitability of the past year is the run rate or the high-water mark. A buyer at today's price is taking the first view.

What the business is doing supports the more patient reading better than the more aggressive one. The 20-F reports a portfolio with an average remaining maturity term of 504 days, and 65% of the Bank's Loan Portfolio was scheduled to mature within one year, so the asset side reprices quickly in either direction. A short book earns less as rates fall and loses less as credit deteriorates. It is a structure built for uncertainty rather than for maximising a spread.

For a bank, the downside is bounded by regulatory capital and payout capacity rather than by any cash-flow cushion. On that measure the position has strengthened: about 1.9 billion dollars of liquid assets at the end of 2025, and a liquidity index reported by the Bank to the regulator as of December 31, 2025 was 60.7 % (2024: 47.2 %). The dividend was raised to $0.6875 a share a quarter. A bank simultaneously building liquidity and raising its payout is not being run for the next quarter, which is the most reassuring thing in the file and the least reflected in a price already at the top of its group.

Catalysts

The next scheduled disclosure is two days out. Bladex publishes second-quarter 2026 results on July 27, 2026, with a conference call the following day. For a bank priced on the durability of its return on equity, the single most informative line in that release is the return itself, followed by the provision charge, because those two together determine whether the current level is a plateau or a peak.

Capital return has already moved this year. The board approved a quarterly cash dividend of $0.6875 per share for the first quarter of 2026, raised from $0.625 the previous quarter, payable May 27, 2026 to holders of record on May 8, 2026. Dividend decisions at a bank are made against a regulator's view of capital adequacy, so an increase is a statement about capital headroom as much as about earnings.

The variables that will decide the next several quarters sit outside the bank. Dollar interest rates set the yield on a portfolio that reprices inside two years, and the credit standing of the Latin American sovereigns where the bank has its largest exposures sets both provisioning and, through the bank's own ratings, the cost of its funding. Neither of those turns on anything management does. Watching them is a better use of attention than watching any single quarter's headline.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Bladex announcement of second-quarter 2026 results date, July 15, 2026 · Bladex quarterly dividend announcement, April 27, 2026

View the full interactive BLX report on boothcheck